ID

35264

Descripción

Study ID: 100449 Clinical Study ID: 100449 Study Title: Long-term Follow-Up studies at Years 16-20, to evaluate the persistence of immune response of GSK Biologicals’ hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00240539 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Palabras clave

  1. 25/2/19 25/2/19 -
Titular de derechos de autor

GSK group of companies

Subido en

25 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Persistence of immune response of Hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers

Visit 22 - 26 (Follow-Up)

Visit 22 (Year 16) Follow-up
Descripción

Visit 22 (Year 16) Follow-up

Protocol
Descripción

Protocol

Tipo de datos

integer

Center
Descripción

Center

Tipo de datos

integer

Date of visit
Descripción

Date of visit

Tipo de datos

date

Subject Number
Descripción

Subject Number

Tipo de datos

integer

INFORMED CONSENT
Descripción

INFORMED CONSENT

I certify that Informed Consent has been obtained prior to any study procedure.
Descripción

I certify that Informed Consent has been obtained prior to any study procedure.

Tipo de datos

boolean

Informed Consent Date
Descripción

InformedConsentDate

Tipo de datos

date

DEMOGRAPHICS
Descripción

DEMOGRAPHICS

Date of birth:
Descripción

PREVIOUS STUDY: 103860/272 (EXT: HBV-115) Subject number will be the same as in the previous study.

Tipo de datos

date

Gender
Descripción

Gender

Tipo de datos

text

Race
Descripción

Race

Tipo de datos

text

If Other, please specify race
Descripción

OtherRace

Tipo de datos

text

Height
Descripción

Height

Tipo de datos

integer

Unidades de medida
  • cm
cm
Weight
Descripción

Weight

Tipo de datos

float

Unidades de medida
  • kg
kg
LABORATORY TESTS
Descripción

LABORATORY TESTS

Has a blood sample been taken?
Descripción

BLOOD SAMPLE

Tipo de datos

boolean

If Yes, please record the date
Descripción

DateBloodSampleTaken

Tipo de datos

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descripción

PreviousHepatitisVaccination

Tipo de datos

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descripción

PreviousHistoryOfHipatitisB

Tipo de datos

boolean

If Yes, please specify below
Descripción

Specify

Tipo de datos

text

Visit 23 (Year 17) Follow-up
Descripción

Visit 23 (Year 17) Follow-up

Date of visit
Descripción

VisitDate

Tipo de datos

date

LABORATORY TESTS
Descripción

LABORATORY TESTS

Has a blood sample been taken?
Descripción

BLOOD SAMPLE

Tipo de datos

boolean

Please specify the date of blood sample taken
Descripción

DateBloodSampleTaken

Tipo de datos

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descripción

PreviousHepatitisBVaccination

Tipo de datos

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descripción

PreviousHistoryOfHepatitisB

Tipo de datos

boolean

If Yes, please specify
Descripción

Specify

Tipo de datos

text

Visit 24 (Year 18) Follow-up
Descripción

Visit 24 (Year 18) Follow-up

Date of visit
Descripción

Visit Date

Tipo de datos

date

LABORATORY TESTS
Descripción

LABORATORY TESTS

Has a blood sample been taken?
Descripción

BLOOD SAMPLE

Tipo de datos

boolean

Please specify the date of blood sample taken
Descripción

DateBloodSampleTaken

Tipo de datos

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descripción

PreviousHepatitisBVaccination

Tipo de datos

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descripción

PreviousHistoryOfHepatitisB

Tipo de datos

boolean

If Yes, please specify
Descripción

Specify

Tipo de datos

text

Visit 25 (Year 19) Follow-up
Descripción

Visit 25 (Year 19) Follow-up

Date of visit
Descripción

VisitDate

Tipo de datos

date

LABORATORY TESTS
Descripción

LABORATORY TESTS

Has a blood sample been taken?
Descripción

BLOOD SAMPLE

Tipo de datos

boolean

Please specify the date of blood sample taken
Descripción

DateBloodSampleTaken

Tipo de datos

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descripción

PreviousHepatitisBVaccination

Tipo de datos

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descripción

PreviousHistoryOfHepatitisB

Tipo de datos

boolean

If Yes, please specify
Descripción

Specify

Tipo de datos

text

Visit 26 (Year 20) Follow-up
Descripción

Visit 26 (Year 20) Follow-up

Date of visit
Descripción

VisitDate

Tipo de datos

date

LABORATORY TESTS
Descripción

LABORATORY TESTS

Has a blood sample been taken?
Descripción

BLOOD SAMPLE

Tipo de datos

boolean

Please specify the date of blood sample taken
Descripción

DateBloodSampleTaken

Tipo de datos

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Descripción

PreviousHepatitisBVaccination

Tipo de datos

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Descripción

PreviousHistoryOfHepatitisB

Tipo de datos

boolean

If Yes, please specify
Descripción

Specify

Tipo de datos

text

FOLLOW-UP STUDIES
Descripción

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Descripción

FollowUpStudiesParticipation

Tipo de datos

boolean

If No, please specify
Descripción

If No, please specify

Tipo de datos

text

If AE or SAE, please specify
Descripción

AE/SAE

Tipo de datos

text

If Other, please specify
Descripción

OtherSpecify

Tipo de datos

text

INVESTIGATOR'S SIGNATURE
Descripción

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Descripción

Investigator'sConfirmationDate

Tipo de datos

date

Investigator's signature
Descripción

Investigator's signature

Tipo de datos

text

Printed Investigator's name
Descripción

Printed Investigator's name

Tipo de datos

text

Reason for non participation
Descripción

Reason for non participation

Protocol number
Descripción

Protocol number

Tipo de datos

integer

Center
Descripción

Center

Tipo de datos

integer

Previous study
Descripción

e.g., 103860 / 272 (EXT:HBV-115)

Tipo de datos

text

Tracking Document
Descripción

Tracking Document

Previous Subject Number
Descripción

Previous Subject Number

Tipo de datos

integer

Date of Birth
Descripción

BirthDate

Tipo de datos

date

Please document reason for non participation
Descripción

Please document reason for non participation

Tipo de datos

text

In case of death, please specify date
Descripción

DeathDate

Tipo de datos

date

Date of Contact
Descripción

Date of Contact

Tipo de datos

date

Investigator's Signature
Descripción

Investigator's Signature

Investigator name
Descripción

please PRINT name

Tipo de datos

text

Signature:
Descripción

Signature:

Tipo de datos

text

Date:
Descripción

Date:

Tipo de datos

date

Similar models

Visit 22 - 26 (Follow-Up)

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Visit 22 (Year 16) Follow-up
Protocol
Item
Protocol
integer
Center
Item
Center
integer
Date of visit
Item
Date of visit
date
Subject Number
Item
Subject Number
integer
Item Group
INFORMED CONSENT
I certify that Informed Consent has been obtained prior to any study procedure.
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
InformedConsentDate
Item
Informed Consent Date
date
Item Group
DEMOGRAPHICS
Date of birth:
Item
Date of birth:
date
Item
Gender
text
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
OtherRace
Item
If Other, please specify race
text
Height
Item
Height
integer
Weight
Item
Weight
float
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
If Yes, please record the date
date
PreviousHepatitisVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHipatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify below
text
Item Group
Visit 23 (Year 17) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 24 (Year 18) Follow-up
Visit Date
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 25 (Year 19) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 26 (Year 20) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
FOLLOW-UP STUDIES
FollowUpStudiesParticipation
Item
Would the subject be willing to participate in a follow-up study?
boolean
Item
If No, please specify
text
Code List
If No, please specify
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
AE/SAE
Item
If AE or SAE, please specify
text
OtherSpecify
Item
If Other, please specify
text
Item Group
INVESTIGATOR'S SIGNATURE
Investigator'sConfirmationDate
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text
Item Group
Reason for non participation
Protocol number
Item
Protocol number
integer
Center
Item
Center
integer
Previous study
Item
Previous study
text
Item Group
Tracking Document
Previous Subject Number
Item
Previous Subject Number
integer
BirthDate
Item
Date of Birth
date
Item
Please document reason for non participation
text
Code List
Please document reason for non participation
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached (2)
CL Item
Subject eligible but not willing to participate due to adverse events, or serious adverse event (3)
CL Item
Subject eligible but not willing to participate due to other reasons (4)
CL Item
Subject died (5)
DeathDate
Item
In case of death, please specify date
date
Date of Contact
Item
Date of Contact
date
Item Group
Investigator's Signature
Investigator name
Item
Investigator name
text
Signature:
Item
Signature:
text
Date:
Item
Date:
date

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial